Skip to main content
Clinical Trials/NL-OMON38910
NL-OMON38910
Completed
Phase 4

Effect of deep neuromuscular block and variations in arterial PCO2 on the surgical rating scale, extubation conditions and postoperative conditions following reversal with sugammadex - BLISS 2

eids Universitair Medisch Centrum0 sites40 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
niercelcarcinoom
Sponsor
eids Universitair Medisch Centrum
Enrollment
40
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • (i) Patients diagnosed with renal or prostatic disease who are will undergo an elective
  • laparoscopic renal surgical procedure or laparoscopic prostatectomy;
  • (ii) ASA class I\-III
  • (iii) \> 18 years of age;
  • (iv) Ability to give oral and written informed consent.

Exclusion Criteria

  • (i) Known or suspected neuromuscular disorders impairing neuromuscular function;
  • (ii) Allergies to muscle relaxants, anesthetics or narcotics;
  • (iii) A (family) history of malignant hyperthermia;
  • (iv) Women who are or may be pregnant or are currently breast feeding;
  • (v) Renal insufficiency, as defined by serum creatinine x 2 of normal, or urine output \< 0\.5
  • ml/kg/h for at least 6 h. When available, other indices will be taken into account as well such
  • as glomerular filtration rate \< 60 ml/h and proteinuria (a ratio of 30 mg albumin to 1 g of
  • creatinine).
  • (vi) Previous retroperitoneal surgery at the site of the current surgery.
  • (vii) Body mass index \> 35 kg/m2

Outcomes

Primary Outcomes

Not specified

Similar Trials